Dr. Saif is recognized as an internationally renowned expert in GI cancers, specifically pancreatic and colorectal cancers. He completed his Bachelor of Medicine & Bachelor of Surgery (M.B.B.S.) in 1993 from King Edward Medical College (KEMC), Lahore, Pakistan. At present, Dr. M. Wasif Saif is Deputy Physician-in-Chief and Medical Director of NorthwellHealth Cancer Institute, Professor of Medical Oncology at Zucker School of Medicine at Hofstra, Professor at Center for Health Innovations and Outcome Research, The Feinstein Institute for Medical Research, and Associate Member at the Cold Spring Harbor Laboratories, USA. Prior to this, he has served in distinct position at the Tufts Medical Center, Boston; Columbia University Medical Center at New York Presbyterian, NY; Yale Cancer Center, New Haven; University of Alabama at Birmingham, and the National Cancer Institute, Bethesda. Over the last two decades, he has served as the principal investigators for multiple prospective cancer clinical trials, including investigator-initiated studies. Many of these clinical studies have also embedded innovative translational research components investigating host-, drug-, and/or tumor-based correlative studies and pharmacogenetics. Throughout his career, he remains extensively involved in the teaching, mentorship and career planning of all levels of medical training starting from medical school student to resident, fellow ad junior faculty. He has contributed to over 600 peer-reviewed publications, and serves on editorial board member of many peer-review journals. He has been asked to speak at both national and international conferences. He continues to serve on grant review committees, including NCI and holds membership in many societies and committees including ASCO, ESMO, ASPECT and many others. Dr. Saif has won many awards and laurels including America’s Top Oncologist and Leading physicians of the World.
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.